Viewing Study NCT03332667


Ignite Creation Date: 2025-12-25 @ 12:45 AM
Ignite Modification Date: 2026-01-01 @ 12:45 PM
Study NCT ID: NCT03332667
Status: COMPLETED
Last Update Posted: 2025-04-16
First Post: 2017-11-02
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: MIBG With Dinutuximab +/- Vorinostat
Sponsor: New Approaches to Neuroblastoma Therapy Consortium
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-09-12
Start Date Type: ACTUAL
Primary Completion Date: 2024-02-23
Primary Completion Date Type: ACTUAL
Completion Date: 2024-02-23
Completion Date Type: ACTUAL
First Submit Date: 2017-11-02
First Submit QC Date: None
Study First Post Date: 2017-11-06
Study First Post Date Type: ACTUAL
Results First Submit Date: 2025-02-20
Results First Submit QC Date: None
Results First Post Date: 2025-04-16
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-03-28
Last Update Post Date: 2025-04-16
Last Update Post Date Type: ACTUAL